BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//PlainTrial//Saved Trials Calendar//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:PlainTrial saved trials
X-WR-CALDESC:Estimated completion dates for the clinical trials you saved o
 n PlainTrial.
BEGIN:VEVENT
UID:plaintrial-NCT05456685-completion@plaintrial.com
DTSTAMP:20261027T194657Z
DTSTART;VALUE=DATE:202611
SUMMARY:Mirvetuximab Soravtansine (MIRV) With Carboplatin in Second-line Tr
 eatment of Folate Receptor Alpha (FRα) Expressing\, Platinum-sensitive Ep
 ithelial Ovarian Cancer — estimated completion date
DESCRIPTION:Active\, not recruiting. Saved on your PlainTrial shortlist. Fu
 ll trial record: https://plaintrial.com/trial/NCT05456685
URL:https://plaintrial.com/trial/NCT05456685
END:VEVENT
END:VCALENDAR